✦ LIBER ✦

Plasma levels and systemic safety of 0.1% unpreserved Timolol maleate gel, 0.5% Timolol aqueous solution and 0.5% Timolol maleate gel

✍ Scribed by Bonnin, N.; Nezzar, H.; Dubray, C.; Renault, D.; Olmiere, C.; Chiambaretta, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Daytime diurnal curve comparison between

✍ Konstas, A G P; Kozobolis, V P; Lallos, N; Christodoulakis, E; Stewart, J A; Ste 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB

Efficacy and systemic side-effects of to

✍ Uusitalo, Hannu ;Niño, Juanita ;Tahvanainen, Kari ;Turjanmaa, Väinö ;Ropo, Auli 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Timolol Maleate 0.5% or 0.1% Gel-Forming

✍ Ajith Chakkittakandiyil; Rod Phillips; Ilona J. Frieden; Elaine Siegfried; Irene 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Short-term tolerability of once-daily ti

✍ Sriram Sonty; Thomas K. Mundorf; Jeanette A. Stewart; William C. Stewart 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Long-term intraocular pressure–lowering

✍ Howard I Schenker; Lewis H Silver 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Improved systemic safety and risk–benefi

✍ Hannu Uusitalo; Mika Kähönen; Auli Ropo; Jukka Mäenpää; Gunilla Bjärnhall; Hans 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 130 KB